The FDA's fast-track nicotine pouch approval plan is running into resistance because regulators and outside critics are still uneasy about the science and the possibility of creating new nicotine ...

David Ellison’s Paramount Skydance has claimed it has “confidence in the speed and certainty of its regulatory pathway” in closing the acquisition of Warner Bros. Discovery in a $111 billion deal. But ...

Meta-owned Facebook announced on March 18 the launch of Creator Fast Track, a new program aimed at helping creators accelerate growth and earnings on the platform. The initiative offers guaranteed pay ...

Meta’s Creator Fast Track programme guarantees three months of pay for established creators willing to build a following on Facebook, after the company paid out a record $3 billion to creators in 2025 ...

Please provide your email address to receive an email when new articles are posted on . Nipocalimab is a potentially steroid sparing, immunoselective treatment designed to block FcRn and target IgG ...

The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson’s, nipocalimab, Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). This ...

(RTTNews) - Aktis Oncology, Inc. (AKTS), Tuesday announced that the U.S. Food and Drug Administration has granted Fast Track designation to AKY-1189 for the treatment of adult patients with locally ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Damian Garde is a reporter at ...

Add Yahoo as a preferred source to see more of our stories on Google. House Democrats have told GOP leaders they will not help pass a $1.2 trillion government funding package through a fast-track ...

House Democrats have informed GOP leaders they will not help pass a funding package through a fast-track process, a source familiar with the matter confirmed to The Hill — complicating Speaker Mike ...

Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...